Gut microbiota and metabolites in myasthenia gravis: Early diagnostic biomarkers and therapeutic strategies.

Kang, Yongbo; Li, Liping; Kang, Xing; Zhao, Yanqin; Cai, Yue

Kang, Yongbo; Li, Liping; Kang, Xing; Zhao, Yanqin; Cai, Yue.

Afiliação

Kang Y; Department of microbiology and immunology, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, China. Electronic address: 657151276@qq.com.
Li L; Department of microbiology and immunology, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, China.
Kang X; Department of microbiology and immunology, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, China.
Zhao Y; Department of microbiology and immunology, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, China.
Cai Y; Department of microbiology and immunology, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, China. Electronic address: 751179212@qq.com.

Clin Immunol ; 245: 109173, 2022 12.

Article em En | MEDLINE | ID: mdl-36351517

Assuntos

Microbioma Gastrointestinal; Miastenia Gravis; Humanos; Disbiose; Miastenia Gravis/diagnóstico; Miastenia Gravis/terapia; Biomarcadores

Palavras-chave

Autoimmune disease; Diagnostic biomarker; Gut microbiota; Myasthenia gravis; Neurological disorder; Potential therapeutic strategies

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal / Miastenia Gravis Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google